TITLE

Elevated levels of nonfasting triglycerides were associated with increased risk for death, MI, and ischemic heart disease

PUB. DATE
January 2008
SOURCE
ACP Journal Club;Jan/Feb2008, Vol. 148 Issue 1, p23
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents a clinical study that investigates whether the level of nonfasting triglycerides predict risk for death, myocardial infarction (MI) and ischemic heart disease in men and women. A cohort study was conducted in Copenhagen, Denmark for a mean of 26 years. The study showed that for every one millimole per liter increase in the level of non-fasting triglycerides led to increasing risk for death, MI and ischemic heart disease in women, and death and MI in men.
ACCESSION #
28694459

 

Related Articles

  • Review: diabetes is not a coronary disease equivalent.  // Evidence Based Medicine;Oct2009, Vol. 14 Issue 5, p5 

    The article presents a review regarding the possibility of patients with diabetes without history of myocardial infarction (MI) to have similar risk to patients with coronary artery disease (CAD) and with previous MI and no diabetes. Researchers conducted a cohort study involving 100 patients...

  • Sex-related differences in prognosis after myocardial infarction: changes from 1978 to 2007. Grau, María; Sala, Cristina; Sala, Joan; Masia, Rafael; Vila, Joan; Subirana, Isaac; Ramos, Rafel; Elosua, Roberto; Brugada, Ramón; Marrugat, Jaume // European Journal of Epidemiology;Nov2012, Vol. 27 Issue 11, p847 

    Women with myocardial infarction (MI) have shown a 28-day survival disadvantage compared with men. However, results were less consistent when considering long-term mortality in 28-day survivors. The aim was to estimate the trends for sex-related differences in the three endpoints considered for...

  • Temporal Trends in Prevalence of Diabetes Mellitus in a Population-Based Cohort of Incident Myocardial Infarction and Impact of Diabetes on Survival. Gandhi, Gunjan Y.; Roger, VÉronique L.; Bailey, Kent R.; Palumbo, Pasquale J.; Ransom, Jeanine E.; Leibson, Cynthia L. // Mayo Clinic Proceedings;Aug2006, Vol. 81 Issue 8, p1034 

    OBJECTIVE: To determine the temporal trends in prevalence of confirmed diabetes mellitus (DM), time from the date DM criteria were met to myocardial infarction (Ml), and impact of DM on survival. SUBJECTS AND METHODS: A retrospective cohort design was used to identify residents of Olmsted...

  • ARE THE FRAMINGHAM AND PROCAM CORONARY HEART DISEASE RISK FUNCTIONS APPLICABLE TO DIFFERENT EUROPEAN POPULATIONS? THE PRIME STUDY. Empcina, J.; Ducimetiere, P.; Arveiler, D.; Ferrieres, J.; Evans, A.; Haas, B.; Bingham, A.; Amouyel, P.; Dallongeville, J. // Journal of Epidemiology & Community Health;Aug2004 Supplement 1, Vol. 58, pA19 

    The article assesses whether the Framingham and PROCAM heart disease risk functions were applicable to men in Belfast and France. External validation study is performed within the PRIME (Prospective Epidemiological Study of Myocardial Infarction) cohort study. Then compared the relative risks of...

  • Elevation of plasma homocysteine levels associated with acute myocardial infarction. Senaratne, Manohara P. J.; Griffiths, Jo; Nagendran, Jayan // Clinical & Investigative Medicine;Aug2000, Vol. 23 Issue 4, p220 

    Objective: To study the effect of acute myocardial infarction (AMI) on plasma homocystein (Hcy) levels, to determine the optimal time to measure this risk factor for coronary artery disease. Design: A prospective case study. Setting: The Division of Cardiac Sciences, Grey Nuns Hospital in...

  • Studies Dispel Myth That Half Of CHD Patients Have No Prior Risk Factors.  // RN;Nov2003, Vol. 66 Issue 11, p18 

    Summarizes findings of two reviews of studies on risk factors in coronary heart disease (CHD). Rates of non-fatal myocardial infarction and death from CHD; Subjects in the studies.

  • Plasminogen Activator Inhibitor 1 Activity and Other Coronary Risk Factors. Von Eyben, Finn Edler; Mouritsen, Ejvind; Holm, Jan; Montvilas, Paulius; Dimcevski, Georg; Suciu, Gabriel; Rasmussen, Inger Helleberg; Kristensen, Lisbeth Langholz; Von Eyben, Rie // Clinical & Applied Thrombosis/Hemostasis;Jan2005, Vol. 11 Issue 1, p55 

    Because only some coronary risk factors have been evaluated for an association with plasma plasminogen activator inhibitor 1 (PAI-1) activity, this cross-sectional study examined the association between 27 coronary risk factors and PAI-1 in 24 healthy persons without coronary heart disease...

  • History of Kidney Stones and the Risk of Coronary Heart Disease. Ferraro, Pietro Manuel; Taylor, Eric N.; Eisner, Brian H.; Gambaro, Giovanni; Rimm, Eric B.; Mukamal, Kenneth J.; Curhan, Gary C. // JAMA: Journal of the American Medical Association;7/24/2013, Vol. 310 Issue 4, p408 

    IMPORTANCE Kidney stone disease is common and may be associated with an increased risk of coronary heart disease (CHD). Previous studies of the association between kidney stones and CHD have often not controlled for important risk factors, and the results have been inconsistent. OBJECTIVE To...

  • Elevated Plasma Homocysteine Level Is an Independent Predictor of Coronary Heart Disease Events in Patients with Type 2 Diabetes Mellitus. Minna Soinio, Daniel; Rönnemaa, Tapani; Marniemi, Jukka; Markku Laakso; Seppo Lehto, Jukka // Annals of Internal Medicine;1/20/2004, Vol. 140 Issue 2, p94 

    Background: High plasma homocysteine level has been associated with increased risk for coronary heart disease (CHD) events in nondiabetic individuals, especially in those with previously diagnosed CHD. In persons with type 2 diabetes mellitus, the association between homocysteine level and...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics